# Cumberland Pharmaceuticals Inc: Form DEF 14A, filed Mar 15, 2023

- Company: [Cumberland Pharmaceuticals Inc](/companies/cpix.md) (CIK 1087294)
- Form: DEF 14A
- Filed: 2023-03-15
- Accepted by EDGAR: Mar 15, 2023, 07:40 ET
- Period: 2023-03-15
- Accession: 0001628280-23-007954
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1087294/000162828023007954/a2022proxystatement1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1087294/000162828023007954/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1087294/000162828023007954/a2022proxystatement1.htm

Filed Mar 15, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-007954. Last ingested by Listed: Oct 26, 2026, 16:41 ET. No prices; not investment advice.